Towards the establishment of a biomedical ontology for the primary Sjogren's Syndrome

被引：0
|
作者：
Pezoulas, Vasileios C. [1 ]
Exarchos, Themis P. [1 ]
Andronikou, Vassiliki [2 ]
Varvarigou, Theodora [2 ]
Tzioufas, Athanasios G. [3 ]
De Vita, Salvatore [4 ]
Fotiadis, Dimitrios, I [1 ]
机构：
[1] Univ Ioannina, Unit Med Technol & Intelligent Informat Syst, Dept Mat Sci & Engn, GR-45110 Ioannina, Greece
[2] Natl Tech Univ Athens, Div Commun Elect & Informat Engn, Sch Elect & Comp Engn, GR-15780 Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Dept Pathophysiolo, Fac Med, GR-15772 Athens, Greece
[4] Udine Univ, Dept Med & Biol Sci, Clin Rheumatol, IT-33100 Udine, Italy
来源：
2018 40TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC) | 2018年
基金：
欧盟地平线“2020”;
关键词：
Primary Sjogren's Syndrome; systemic autoimmune disease; exocrine gland dysfunction; reference model; biomedical ontology; ACTIVITY IMPAIRMENT QUESTIONNAIRE; WORK PRODUCTIVITY; GEOEPIDEMIOLOGY; LYMPHOMAS;
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Primary Sjogren's Syndrome (pSS) has been characterized as a hypersensitivity reaction type II systemic autoimmune chronic disease causing exocrine gland dysfunction mainly affecting women near the menopausal age. pSS patients exhibit dryness of the main mucosal surfaces and are highly prone to lymphoma development. This paper presents a first biomedical ontology for pSS based on a reference model which was determined by pSS clinical experts. The ensuing ontology constitutes the fundamental basis for mapping pSS-related ontologies from international cohorts to a common ontology. The ontology mapping (i. e., schematic interlinking) procedure is, in fact, a preliminary step to harmonize heterogeneous medical data obtained from various cohorts.
引用
收藏
页码：4089 / 4092
页数：4
相关论文
共 50 条
  • [1] Establishment of an Inducible Model of Primary Sjogren's Syndrome (pSS) in Mice
    Jiang, G.
    Ke, Y.
    Sun, D.
    Kaplan, H. J.
    Shao, H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [2] Sjogren's Syndrome Mortality in primary Sjogren's Syndrome
    Ruchalla, Elke
    AKTUELLE RHEUMATOLOGIE, 2016, 41 (04) : 279 - 279
  • [3] Primary Sjogren's Syndrome
    Mariette, Xavier
    Criswell, Lindsey A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (10): : 931 - 939
  • [4] Primary Sjogren's syndrome
    Brito-Zeron, Pilar
    Ramos-Casals, Manuel
    DRUGS OF THE FUTURE, 2008, 33 (09) : 793 - 802
  • [5] Primary Sjogren's syndrome
    Rischmueller, Maureen
    Tieu, Joanna
    Lester, Susan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (01): : 189 - 220
  • [6] Primary Sjogren's syndrome
    Bowman, S. J.
    LUPUS, 2018, 27 : 32 - 35
  • [7] Seronegative primary Sjogren's syndrome, a distinct subtype of primary Sjogren's syndrome in Chinese patients
    Lan, Jingying
    Deng, Chaoqiong
    Huang, Heqing
    Rao, Peishi
    Chen, Yangchun
    Shi, Yingying
    Chen, Jie
    Shi, Guixiu
    Liu, Yuan
    Chen, Shiju
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [8] Towards visualizing primary Sjogren's Syndrome data from heterogeneous cohorts
    Polychronidou, Eleftheria
    Kalamaras, Ilias
    Votis, Kostantinos
    Tzovaras, Dimitrios
    10TH HELLENIC CONFERENCE ON ARTIFICIAL INTELLIGENCE (SETN 2018), 2018,
  • [9] Methotrexate in primary Sjogren's syndrome
    Skopouli, FN
    Jagiello, P
    Tsifetaki, N
    Moutsopoulos, HM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (05) : 555 - 558
  • [10] Zidovudine in primary Sjogren's syndrome
    Steinfeld, SD
    Demols, P
    Van Vooren, JP
    Cogan, E
    Appelboom, T
    RHEUMATOLOGY, 1999, 38 (09) : 814 - 817
12345